Literature DB >> 21554431

Palmitoylethanolamide stimulation induces allopregnanolone synthesis in C6 Cells and primary astrocytes: involvement of peroxisome-proliferator activated receptor-α.

G Mattace Raso1, E Esposito, S Vitiello, A Iacono, A Santoro, G D'Agostino, O Sasso, R Russo, P V Piazza, A Calignano, R Meli.   

Abstract

Palmitoylethanolamide (PEA) regulates many pathophysiological processes in the central nervous system, including pain perception, convulsions and neurotoxicity, and increasing evidence points to its neuroprotective action. In the present study, we report that PEA, acting as a ligand of peroxisome-proliferator activated receptor (PPAR)-α, might regulate neurosteroidogenesis in astrocytes, which, similar to other glial cells and neurones, have the enzymatic machinery for neurosteroid de novo synthesis. Accordingly, we used the C6 glioma cell line and primary murine astrocytes. In the mitochondrial fraction from cells stimulated with PEA, we demonstrated an increase in steroidogenic acute regulatory protein (StAR) and cytochrome P450 enzyme (P450scc) expression, both comprising proteins considered to be involved in crucial steps of neurosteroid formation. The effects of PEA were completely blunted by GW6471, a selective PPAR-α antagonist, or by PPAR-α silencing by RNA interference. Accordingly, allopregnanolone (ALLO) levels were increased in supernatant of PEA-treated astrocytes, as revealed by gas chromatography-mass spectrometry, and this effect was inhibited by GW6471. Moreover, PEA showed a protective effect, reducing malondialdehyde formation in cells treated with l-buthionine-(S,R)-sulfoximine, a glutathione depletor and, interestingly, the effect of PEA was partially inhibited by finasteride, a 5α-reductase inhibitor. A similar profile of activity was demonstrated by ALLO and the lack of an additive effect with PEA suggests that the reduction of oxidative stress by PEA is mediated through ALLO synthesis. The present study provides evidence indicating the involvement of the saturated acylethanolamide PEA in ALLO synthesis through PPAR-α in astrocytes and explores the antioxidative activity of this molecule, confirming its homeostatic and protective role both under physiological and pathological conditions.
© 2011 The Authors. Journal of Neuroendocrinology © 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21554431     DOI: 10.1111/j.1365-2826.2011.02152.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  22 in total

Review 1.  Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain.

Authors:  Stephen D Skaper; Laura Facci; Mariella Fusco; Maria Federica Della Valle; Morena Zusso; Barbara Costa; Pietro Giusti
Journal:  Inflammopharmacology       Date:  2013-11-01       Impact factor: 4.473

Review 2.  Metabolic and Inflammatory Adaptation of Reactive Astrocytes: Role of PPARs.

Authors:  José Iglesias; Ludis Morales; George E Barreto
Journal:  Mol Neurobiol       Date:  2016-03-17       Impact factor: 5.590

3.  Palmitoylethanolamide protects against the amyloid-β25-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease.

Authors:  Giuseppe D'Agostino; Roberto Russo; Carmen Avagliano; Claudia Cristiano; Rosaria Meli; Antonio Calignano
Journal:  Neuropsychopharmacology       Date:  2012-03-14       Impact factor: 7.853

Review 4.  Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide.

Authors:  Stephen D Skaper; Laura Facci
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

Review 5.  Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator.

Authors:  Stephen D Skaper; Laura Facci; Pietro Giusti
Journal:  Mol Neurobiol       Date:  2013-06-28       Impact factor: 5.590

6.  Allopregnanolone attenuates Aβ25-35-induced neurotoxicity in PC12 cells by reducing oxidative stress.

Authors:  Xiaowei Qian; Hong Cao; Qian Ma; Qinsai Wang; Wei He; Peishun Qin; Bin Ji; Kaiming Yuan; Fanghua Yang; Xuhua Liu; Qingquan Lian; Jun Li
Journal:  Int J Clin Exp Med       Date:  2015-08-15

7.  Steroidogenic acute regulatory protein expression in the central nervous system.

Authors:  Steven R King; Douglas M Stocco
Journal:  Front Endocrinol (Lausanne)       Date:  2011-11-10       Impact factor: 5.555

8.  Site-specific and time-dependent activation of the endocannabinoid system after transection of long-range projections.

Authors:  Sonja Kallendrusch; Constance Hobusch; Angela Ehrlich; Simone Ziebell; Natsuo Ueda; Gerd Geisslinger; Marco Koch; Faramarz Dehghani
Journal:  PLoS One       Date:  2012-03-22       Impact factor: 3.240

9.  Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson's disease.

Authors:  Emanuela Esposito; Daniela Impellizzeri; Emanuela Mazzon; Irene Paterniti; Salvatore Cuzzocrea
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

10.  Finasteride Has Regionally Different Effects on Brain Oxidative Stress and Acetylcholinesterase Activity in Acute Thioacetamide-Induced Hepatic Encephalopathy in Rats.

Authors:  Dušan Mladenović; Nataša Petronijević; Tihomir Stojković; Milica Velimirović; Gordana Jevtić; Dragan Hrnčić; Tatjana Radosavljević; Aleksandra Rašić-Marković; Nebojša Maksić; Dragan Djuric; Olivera Stanojlović
Journal:  PLoS One       Date:  2015-08-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.